You are here

Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials

Massimo Di Maio, Ciro Gallo, Natasha B. Leighl et al.

Published online before print January 26, 2015, doi: 10.1200/JCO.2014.57.9334

Editors’ comment: Dr. Ricardo Caponero

It is well known that physicians under-report adverse events. This paper describes the disagreement between patient and physician reporting in three randomized trials and shows again our difficulty in adequately recording patient’s symptoms. This work reinforces the necessity of patient-reported outcomes as a standard method to evaluate adverse events in and outside clinical trials.

Search this site

Featured videos

Free access to ebooks on cachexia and CINV

 

Prevention of nausea and vomiting in
adult cancer patients receiving tumour-
directed therapy – 2017 update –

and
Cancer cachexia: mechanisms and progress in treatment

 

Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo

Share